Overview
Malignant insulinoma is a rare neuroendocrine tumor of the pancreas characterized by excessive insulin secretion leading to hypoglycemia, often requiring surgical intervention for definitive management 12.Diagnosis
Clinical Presentation: Hypoglycemia with associated symptoms like neuroglycopenia 2.
Laboratory Tests: Fasting hypoglycemia, elevated insulin levels with suppressed C-peptide, and inappropriately high proinsulin levels 2.
Imaging: CT, MRI, or somatostatin receptor scintigraphy (SRS) to localize the tumor 1.
Histopathology: Confirmation through surgical resection and pathology examination 12.Management
Surgical Resection: Primary treatment, aiming for complete removal of the tumor 12.
Adjuvant Therapy: For malignant cases, consider somatostatin analogs (e.g., octreotide) for symptom control and tumor stabilization 1.
Supportive Care: Manage hypoglycemia with glucose infusions and adjust diet to prevent fasting 2.Special Populations
Comorbidities: Concurrent abdominal tuberculosis complicates diagnosis and management, necessitating thorough evaluation during exploratory surgery 1.
Neurological Impact: Patients may present with peripheral neuropathy and neuropsychiatric symptoms, which can improve post-surgery 2.Key Recommendations
Perform comprehensive imaging including SRS to accurately localize insulinoma before surgical intervention (Evidence: Moderate) 1.
Prioritize surgical resection for definitive treatment, considering adjuvant somatostatin analogs for malignant cases (Evidence: Moderate) 12.
Evaluate for and manage concurrent conditions like abdominal tuberculosis during surgical exploration (Evidence: Weak) 1.References
1 Brooks M. Insulinoma and abdominal tuberculosis. Scottish medical journal 1988. link
2 Jayasinghe KS, Nimalasuriya A, Dharmadasa K. A case of insulinoma with peripheral neuropathy. Postgraduate medical journal 1983. link